Patient care & clinical trials

Addenbrooke’s Hospital is a national and regional centre for many cancer types, including lung cancer treatment at Papworth Hospital. We see around 6,000 new patients each year providing the highest quality clinical care backed up by some of the finest cancer science in the world. The 5 year survival rates for our patients are better than the national average for prostate, oesophageal, pancreatic and breast cancers. Over half of cancer patients in the Cambridge region take part in clinical trials - the highest proportion of patients in trials across the UK.

Cancer treatment and care
The diagnosis, treatment and support for cancer patients is provided by Addenbrooke’s Hospital, where around 90 clinical consultants are members of the Cambridge Cancer Centre.
Cambridge Cancer Trials Centre
Cambridge has the highest proportion of cancer patients taking part in clinical trials. These trials will benefit patients in terms of earlier detection and diagnosis, more effective treatments and improved care.
Cambridge Cancer Trials Centre
Clinical trials
Cambridge is the regional referral centre for breast, ovarian, prostate, pancreatic, renal, and lung cancers (at Papworth Hospital). Innovative research by Cambridge scientists is improving patient treatment and care.
Clinical trials

Subscribe to Centre News Latest news from the CRUK Cambridge Centre

A simple test for Barrett's oesophagus, developed in Cambridge, will be trialled in GP surgeries across the UK.
Study of the DNA of over 25,000 ovarian cancer patients sheds light on the genetic causes of ovarian cancer.
Cambridge scientists are set to play a key role in the development of new treatments for pancreatic cancer after a £10 million investment from Cancer Research UK.